The Role of Effluent Analysis and Culture in Diagnosis and Monitoring of Peritoneal Dialysis-Related Peritonitis

Authors

  • Nuri Dyah Indrasari Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta
  • Najib Ali Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta

DOI:

https://doi.org/10.24293/ijcpml.v30i2.1900

Keywords:

End-stage renal disease, peritoneal dialysis, effluent analysis, effluent culture

Abstract

Peritoneal Dialysis (PD) is one of the available renal replacement therapy options for End-Stage Renal Disease (ESRD). One of the most common complications of PD is peritonitis. A 13-year-old boy was admitted to the hospital due to cloudy effluent and abdominal pain four days before admission. He was diagnosed with ESRD in 2015 and has undergone Continuous Ambulatory Peritoneal Dialysis (CAPD) since 2017. The physical examination findings were as follows: the temperature was 36.6 C, the conjunctiva was anemic, the abdomen was tender, and both of the lower extremities were edematous. Peritoneal dialysis effluent analysis showed yellow and turbid effluent with a leukocyte count of 13.346 cells/µL and polymorphonuclear (PMN) cells predominance (69.3%), effluent and serum urea of 221 and 243 mg/dL, effluent and serum creatinine of 16.7 and 18.26 mg/dL, respectively. Effluent Gram stain showed increased leukocytes without bacteria, while effluent culture showed the growth of Methicillin-sensitive Staphylococcus aureus. According to the International Society of Peritoneal Dialysis 2022 guidelines, all criteria for infective peritonitis in this patient were met: clinical features (turbid effluent and abdominal pain), increased cell count (>100 cells/µL) with PMN >50%, and positive effluent culture. The patient was administered intravenous Ampicillin-Sulbactam based on the effluent culture and antimicrobial susceptibility testing. Serial effluent analyses suggested a return-to-normal trend in leukocyte and PMN counts. After 18 days of hospitalization, the patient was allowed to discharge based on clinical and laboratory improvements.

Downloads

Download data is not yet available.

References

Ahn SY, Moxey-Mims M. CKD in children: The importance of a national epidemiologic study. Am J Kidney Dis, 2018; 72: 628.

Starr MC, Hingorani SR. The pediatric patient with chronic kidney disease. In: Chronic kidney disease, dialysis, and transplantation. Himmelfarb J, Ikizler TA, editors, 4th Ed., Philadelphia, Elsevier, 2019; 87.

Fraser N, Hussain FK, Conell R, Shenoy MU. Chronic peritoneal dialysis in children. Int J Nephrol Renovasc Dis, 2015; 8: 125–37.

Keita Y, Ndongo AA, Engome CB, Sow NF, Sek N, Thiam L, et al. Continuous Ambulatory Peritoneal Dialysis (CAPD) in children: A successful case for a bright future in a developing country. Pan Afr Med J, 2019; 33: 71.

Rippe B. Peritoneal dialysis: Principles, techniques, and adequacy. In: Comprehensive clinical nephrology, Floege J, Johnson RJ, Feehally J, editors, 6th Ed., New York, Elsevier, 2018; 1103.

Ambarsari CG, Trihono PP, Kadaristiana A, Tambunan T, Mushahar L, Puspitasari HA, Hidayati EL, Pardede SO. Five-year experience of continuous ambulatory peritoneal dialysis in children: A single center experience in a developing country. Med J Indones, 2019; 28(4): 329-37.

Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISDP peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int, 2022; 42(2): 110-53.

Chada V, Schaefer FS, Warady BA. Dialysis-associated peritonitis in children. Pediatr Nephrol, 2010; 25(3): 425–40.

Dossin T, Goffin E. When the color of peritoneal dialysis effluent can be used as a diagnostic tool. Seminars in Dialysis, 2019; 32: 72–9.

Vardhan A, Hutchison AJ. Peritoneal dialysis. In: National Kidney Foundation’s primer on kidney diseases, Gilbert SJ, Weiner DE, editors, 7th Ed., New York, Elsevier, 2018; 539-544.

AlZabli SM, Alsuhaibani MA, BinThunian MA, Alshahrani DA, Al Anazi A, et al. Peritonitis in children on peritoneal dialysis: 12 years of tertiary center experience. Int J Pediatr Adolesc Med, 2021; 8(4): 229-235.

Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, Leung CB, Li PK. Staphylococcus aureus peritonitis complicates peritoneal dialysis: Review of 245 consecutive cases. Clin J Am Soc Nephrol, 2007; 2(2): 245-51.

Mantovani A, Garlanda C. Humoral innate immunity and acute-phase proteins. N Engl J Med, 2023; 388: 439-52.

Jasihankar D. Secondary thrombocytosis. Available at: https://emedicine.medscape.com/article/206811-overview#a5 (accessed Nov 25, 2022).

Portolés J, Martín L, Broseta JJ, Cases A. Anemia in chronic kidney disease: From pathophysiology and current treatments to future agents. Front Med, 2021; 8: 642296.

Gauckler P, Shin JI, Mayer G, Kronbichler A. Eosinophilia and kidney disease: More than just an incidental finding?. J Clin Med, 2018; 7(529): 1, 14-15.

Song P, Yang D, Li J, Zhuo N, Fu X, et al. Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China. Front Med, 2022; 9: 917603.

Dhondup T, Qi Q. Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif, 2017; 43(1-3): 184–5.

Downloads

Submitted

2021-07-15

Accepted

2023-07-26

Published

2024-02-16

How to Cite

[1]
Indrasari, N.D. and Ali, N. 2024. The Role of Effluent Analysis and Culture in Diagnosis and Monitoring of Peritoneal Dialysis-Related Peritonitis. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 2 (Feb. 2024), 197–201. DOI:https://doi.org/10.24293/ijcpml.v30i2.1900.

Issue

Section

Case Report